SPINK6 gene

Last updated on: 10.05.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

SPINK is the acronym for "Serine Peptidase Inhibitor Kazal" and comprises a gene family placed on different chromosomes. The members of this gene family code for the specific proteases, the Kazal-type SPINK protease inhibitor family (SPINK). These are serine peptidase inhibitors. They contain at least one inhibitory Kazal domain. This domain binds to its target, the serine proteases, and inhibits their proteolytic functions. This regulatory inhibitory function and its fine-tuning is fundamental for many epithelia.

General informationThis section has been translated automatically.

SPINK6 (Kazal-type 6 serine protease inhibitor) was identified as a selective inhibitor of "Extracellular kallikrein-related peptidases (KLKs) in human stratum corneum extracts.

Immunohistochemical analysis revealed SPINK6 expression in the stratum granulosum of human skin at various anatomical locations and in skin appendages, including sebaceous and sweat glands. SPINK6 expression is decreased in lesions of atopic dermatitis (Meyer-Hoffert U et al. 2010).

SPINK6 plays a role in modulating the activity of KLKs (kallikrein-related peptidases) in human skin. Selective inhibition of KLKs by SPINK6 may have therapeutic potential when KLK activity is elevated. KLKs are involved in the desquamation process of the epidermis and in the initiation of epidermal inflammation through different mechanisms. Their action is tightly controlled by specific protease inhibitors.

SPINK6 is expressed in the same localization as transglutaminases (TGM). The protease inhibitor also contains TGM substrate motifs. Recombinant SPINK6 was shown to be cross-linked to fibronectin (FN) by TGM1. Conjugated SPINK6 showed protease inhibitory activity in keratinocytes and stratum corneum extracts. Cross-linked SPINK6 protected fibronectin from extracellular kallikrein-related peptidase (KLK5)-mediated cleavage.

LiteratureThis section has been translated automatically.

  1. Fischer J et al (2013) Cross-linking of SPINK6 by transglutaminases protects from epidermal proteases. J Invest Dermatol 133:1170-1177.
  2. Meyer-Hoffert U et al (2010) Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases. J Biol Chem 285:32174-32181.

Last updated on: 10.05.2021